With shares well below recent highs, this ASX 200 stock is back on my radar. Here’s why I’m planning to buy it in 2026.

In 2025, the medtech industry saw another year full of all kinds of deals in the mergers and acquisitions (M&A) arena.

Positron Corporation (OTC: POSC) (the 'Company”), a leading molecular imaging medical device company specializing in Positron ...

Overview: Unity and Unreal Engine dominate VR development with robust ecosystems, cross-platform support, and ...

Dental AI company Pearl has marked several accomplishments this year, including FDA clearances and industry partnerships. Here are 13 updates from the company in 2025: 1. Pearl was granted FDA 510(k) ...

In 2026, several Android flagships deliver features that clearly outshine the iPhone 17 Pro. From 200MP camera phones and 8K ...

The OnePlus 16 is still nearly a year away, but early rumors hint at a meaningful camera overhaul. If the latest leak holds, ...

The Leica Edition sits at the premium end of Xiaomi’s offerings, reflecting both the partnership with Leica and the added ...

GE HealthCare Technologies Inc. (NYSE: GEHC) leads with 100 FDA-approved AI devices, concentrating heavily on imaging and diagnostics. Their CleaRecon DL technology sharpens cone-beam CT images using ...

Reincarnation and generative AI are increasingly getting attention, doing so on a surprisingly paired-up basis. Here's the ...

Here’s everything you need to know about astrophotography in January 2026: ...

Samsung has announced the Galaxy A17 5G, positioning it for affordable buyers who want modern features without a premium ...